These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 27917793)

  • 21. Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety.
    Santos J; Planas R; Pardo A; Durández R; Cabré E; Morillas RM; Granada ML; Jiménez JA; Quintero E; Gassull MA
    J Hepatol; 2003 Aug; 39(2):187-92. PubMed ID: 12873814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system.
    Pérez-Ayuso RM; Arroyo V; Planas R; Gaya J; Bory F; Rimola A; Rivera F; Rodés J
    Gastroenterology; 1983 May; 84(5 Pt 1):961-8. PubMed ID: 6339312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognosis of refractory ascites in cirrhosis.
    Ennaifer R; Elleuch N; Romdhane H; Hefaiedh R; Cheikh M; Chaabouni S; Ben Nejma H; Bel Hadj N
    Tunis Med; 2016 Jan; 94(1):12-5. PubMed ID: 27525599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
    Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
    Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of captopril therapy on sodium and water excretion in patients with liver cirrhosis and ascites].
    Brunkhorst R; Wrenger E; Kühn K; Schmidt FW; Koch K
    Klin Wochenschr; 1989 Aug; 67(15):774-83. PubMed ID: 2671477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous high-dose furosemide and hypertonic saline solutions for refractory heart failure and ascites.
    Tuttolomondo A; Pinto A; Parrinello G; Licata G
    Semin Nephrol; 2011 Nov; 31(6):513-22. PubMed ID: 22099508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic program for ascites. Recommendations from the Swedish Society of Gastroenterology and Gastrointestinal Endoscopy].
    Lööf L; Prytz H; Söderlund C; Wallerstedt S
    Lakartidningen; 2001 Dec; 98(49):5649-52, 5655. PubMed ID: 11783052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: a randomized prospective study.
    Choi CH; Ahn SH; Kim DY; Lee SK; Park JY; Chon CY; Moon YM; Han KH
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1215-22. PubMed ID: 16048569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.
    Paterna S; Di Pasquale P; Parrinello G; Fornaciari E; Di Gaudio F; Fasullo S; Giammanco M; Sarullo FM; Licata G
    J Am Coll Cardiol; 2005 Jun; 45(12):1997-2003. PubMed ID: 15963399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: a cross-over study.
    Sersté T; Francoz C; Durand F; Rautou PE; Melot C; Valla D; Moreau R; Lebrec D
    J Hepatol; 2011 Oct; 55(4):794-9. PubMed ID: 21354230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of different therapeutic approaches for spontaneous bacterial peritonitis.
    Abd Elaal MM; Zaghloul SG; Bakr HG; Ashour MA; Abdel-Aziz-El-Hady H; Khalifa NA; Amr GE
    Arab J Gastroenterol; 2012 Jun; 13(2):65-70. PubMed ID: 22980594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver: diuretic agents for ascites: joining forces from the start?
    Ginès P
    Nat Rev Gastroenterol Hepatol; 2010 Jun; 7(6):310-1. PubMed ID: 20523351
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of adding hypertonic saline solutions and/or etilefrine to standard diuretics therapy in cirrhotic patients with ascites.
    Radwan H; Ibrahim O; Badra G; El-Said H; El-Haggar S
    Eur Rev Med Pharmacol Sci; 2022 Sep; 26(18):6608-6619. PubMed ID: 36196711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of three diuretic treatment strategies for patients with acute decompensated heart failure.
    Yayla Ç; Akyel A; Canpolat U; Gayretli Yayla K; Eyiol A; Akboğa MK; Türkoğlu S; Tavil Y; Boyacı B; Çengel A
    Herz; 2015 Dec; 40(8):1115-20. PubMed ID: 26135463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.
    Arroyo V; Ginès P; Planas R
    Gastroenterol Clin North Am; 1992 Mar; 21(1):237-56. PubMed ID: 1568775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Paracentesis combined with albumin infusion in the treatment of tense ascites in cirrhotic patients].
    Chesta J; Brahm J; Latorre R; Gidi J; Hurtado C; Antezana C; Novoa X; Velasco M
    Rev Med Chil; 1990 Aug; 118(8):874-80. PubMed ID: 2152231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of midodrine and albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients: a randomized pilot study.
    Hamdy H; ElBaz AA; Hassan A; Hassanin O
    J Clin Gastroenterol; 2014 Feb; 48(2):184-8. PubMed ID: 23842215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective study comparing human albumin vs. reinfusion of ultrafiltrate-ascitic fluid after total paracentesis in cirrhotic patients with tense ascites.
    Zaak D; Paquet KJ; Kuhn R
    Z Gastroenterol; 2001 Jan; 39(1):5-10. PubMed ID: 11215366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Factors Predicting the Effect of Tolvaptan for Refractory Ascites in Patients with Decompensated Liver Cirrhosis.
    Chishina H; Hagiwara S; Nishida N; Ueshima K; Sakurai T; Ida H; Minami Y; Takita M; Kono M; Minami T; Iwanishi M; Umehara Y; Watanabe T; Komeda Y; Arizumi T; Kudo M
    Dig Dis; 2016; 34(6):659-664. PubMed ID: 27750234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short-term effects of hypertonic saline solution in acute heart failure and long-term effects of a moderate sodium restriction in patients with compensated heart failure with New York Heart Association class III (Class C) (SMAC-HF Study).
    Paterna S; Fasullo S; Parrinello G; Cannizzaro S; Basile I; Vitrano G; Terrazzino G; Maringhini G; Ganci F; Scalzo S; Sarullo FM; Cice G; Di Pasquale P
    Am J Med Sci; 2011 Jul; 342(1):27-37. PubMed ID: 21701268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.